<![CDATA["DARATUMUMAB APPEARS to be the "gift that keeps on giving"]]>"DARATUMUMAB APPEARS to be the "gift that keeps on giving" to the myeloma community. "It seems we can add daratumumab to almost anything and make the regimen better. It's got good activity and a good safety profile," said Kenneth Shain, MD, PhD, Director of the Myeloma Working Group at Moffitt Cancer Center, Tampa, who commented on the benefit observed by adding the monoclonal antibody to doublets and triplets in trials described at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition".

Læs mere

Document Moved

favicon

(www.ascopost.com)

]]>https://dev.proinvestor.com/forum/topic/440118/daratumumab-appears-to-be-the-gift-that-keeps-on-givingRSS for NodeWed, 15 Jul 2026 16:42:29 GMTMon, 25 Mar 2019 08:22:06 GMT60